Dr. Noam VanderWalde (Co-Chief Resident, PGY 5)



  • Undergraduate:  University of Pennsylvania, Philadelphia, PA
  • Medical School:  University of Maryland School of Medicine, Baltimore, MD
  • Internship: Internal Medicine, Mercy Medical Center, Baltimore, MD

Honors and Awards

Medical School:

  • Children's Hospital of Los Angeles/USC Keck School of Medicine Summer Oncology Fellowship program, 2006


  • Travel award to attend the ASCO/AACR Vail Workshop in “Methods in Clinical Cancer Research”, July, 2012
  • Alpha Omega Alpha Postgraduate Award, October, 2012
  • Travel award to attend the Joint Hematology/Oncology Alliance for Clinical Trials in Oncology Meeting, and the Cancer and Aging Research Group U13 Conference, November, 2012
  • UNC Lineberger Comprehensive Cancer Center Clinical/Translational Developmental Research Award, July, 2013

Research Interests

Geriatric oncology; Health Services research; Head and neck, breast and lung cancers


(as of 10/20/13)

  • Vanderwalde NA, Herbert B, Jones E, Muss H.  The role of adjuvant radiation treatment in older women with early breast disease.   J Geriat Oncol 4(3):262-270, 2013.  PMID: 24058388.
  • Vanderwalde NA, Fleming M, Weiss J, Chera BS.  Treatment of older patients with head and neck cancer: a review.  Oncologist 18(5):568-578, 2013. PMID: 23635557.
  • Rackoff A, Schenkel S, VanderWalde N. Woman with persistent cough. J Emerg Med 44(1):e71-72, 2013. PMID: 22075537.
  • VanderWalde N, Jones E, Kimple R, Moore D, Demore N, Sartor C, Ollila D. Phase II study of pre-excision single dose intraoperative radiation therapy (IORT) for early stage breast cancers: six year update with application of the ASTRO Accelerated Partial Breast Irradiation Consensus Statement criteria. Cancer 119(9):1736-1743, 2013. PMID: 23361892.
  • VanderWalde NA, Fried DV, Kostich MV, Schreiber EC, Chera BS. A dosimetric study of the effect of patient positioning on the incidental radiation dose to the larynx for patients treated for head and neck squamous cell carcinoma. (Abstract.)  American Society for Radiation Oncology Annual Meeting, Boston, MA, October, 2012. (Poster presentation.)
  • VanderWalde NA, Meyer AM, Zullig LL, Tyree SD, Carpenter WR, Weissler MC, Shores CG, Hayes N, Chera BS. Patterns of care in elderly patients with squamous cell carcinoma of the head and neck: a SEER-Medicare Analysis. (Abstract.)  American Society of Clinical Oncology Annual Meeting, Chicago, IL, June, 2012. (Poster presentation.)
  • Neuner G, Mohiuddin M, VanderWalde N, Goulobeva O, Ha J, Yu C, Regine W. High dose spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with Cerrobend vs. MLC SFGRT.  Int J Radiat Oncol Biol Phys 82(5):1642-1649, 2012. PMID: 21531514.
  • VanderWalde N, Tyree S, Meyer AM, Carpenter W, Muss H, Shores C, Weissler M, Hayes N, Chera B.  SEER-Medicare Analysis of Patterns of Care for Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. (Abstract.)  Multidisciplinary Head and Neck Cancer Symposium, Phoenix, AZ, January, 2012. (Poster presentation.)
  • VanderWalde NA, Ollila DW, DeMore NK, Moore DT, Kimple RJ, Kuzmiak CM, Pavic D, Sartor CI, Lian J, Jones EL. Local recurrence outcomes in Phase II clinical trial using single dose intraoperative radiotherapy (IORT) before surgical excision of early-stage breast cancer. (Abstract.)  American Society for Radiation Oncology Annual Meeting, Miami, FL, October, 2011.  (Oral presentation.)
  • VanderWalde N, Moore K, Bernheimer J. Paraneoplastic cerebellar degeneration in a patient with unknown primary tumor (Abstract.) American College of Physicians Maryland Region Annual Associates Meeting, Baltimore, Maryland, May, 2010. (Poster presentation.)
  • Butturini A, Jacob M, Aguajo J, VanderWalde N, Villablanca J, Jubran R, Epstein A, Marachelian A, Dhall G, Finlay J. High-dose chemotherapy and autologous hematopoietic stem cell transplant in children with recurred medulloblastoma and supratentorial primitive neuro-ectodermal tumors: the impact of prior radiotherapy on post transplant outcome. Cancer 115(13):2956-2963, 2009. PMID: 19402050.